Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricVRTXVertex PharmaceuticalsGILDGilead SciencesREGNRegeneron Pharmaceuticals
Snapshot
Price$519.39$153.15$808.70
Market cap$115.02B$162.98B$68.59B
Valuation
P/E28.7x20.5x19.1x
Forward P/E27x14.6x18.3x
Growth
Revenue growth10.1%3.5%5.9%
EPS growth6.1%55.5%4.4%
Profitability
Net margin35.5%31.0%29.6%
ROE23.9%42.2%14.3%
Balance sheet & cash
Debt / equity0.01x1.1x0.09x
Free cash flow yield3.1%5.2%6.3%
Dividend yield—2.6%0.6%
Verdict
Investment ratingFavorable· 67Strong· 74Favorable· 69

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearVRTXtoday $519GILDtoday $153REGNtoday $809
2027$413.38 – $606.29+17% CAGR$178.60 – $261.95+71% CAGR$633.21 – $928.71+15% CAGR
2028$438.68 – $643.40+11% CAGR$277.70 – $407.30+63% CAGR$661.07 – $969.57+9% CAGR
2029$465.53 – $682.78+10% CAGR$431.80 – $633.31+61% CAGR$690.16 – $1,012.24+8% CAGR
2030$494.02 – $724.56+9% CAGR$671.41 – $984.74+59% CAGR$720.53 – $1,056.77+7% CAGR
2031$524.25 – $768.90+8% CAGR$1,043.98 – $1,531.17+58% CAGR$752.23 – $1,103.27+6% CAGR
5-yr CAGR0.2% – 8.2%46.8% – 58.5%-1.4% – 6.4%